Abstract
A convenient approach to antimalarial drug discovery is the use of the organic scaffold of a known antimalarial drug and an organometallic moiety to alter its unwanted properties and/or to optimize its initial effects. This minireview focuses mainly on the discovery of ferroquine, which has emerged from a collaborative French discovery project, and efforts to understand its mechanism of action and resistance.
MeSH terms
-
Aminoquinolines / pharmacology*
-
Animals
-
Antimalarials / pharmacology*
-
Chloroquine / pharmacology*
-
Clinical Trials, Phase I as Topic
-
Drug Resistance
-
Ferrous Compounds / pharmacology*
-
Metallocenes
-
Organometallic Compounds / pharmacology*
-
Plasmodium falciparum / drug effects*
Substances
-
Aminoquinolines
-
Antimalarials
-
Ferrous Compounds
-
Metallocenes
-
Organometallic Compounds
-
Chloroquine
-
ferroquine